Efficacy of chlorfenapyr-pyrethroid and piperonyl butoxide-pyrethroid long-lasting insecticidal nets (LLINs) compared to pyrethroid-only LLINs for malaria control in Côte d'Ivoire: a three group, cluster randomised trial.
Cluster randomised trials
Côte d’Ivoire
Dual-active long-lasting insecticidal nets
Entomological inoculation rate
Insecticide resistance
Insecticides
Interceptor® G2
MAGNet®
Malaria case incidence
Malaria prevalence
VEERALIN®
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
28 Feb 2024
28 Feb 2024
Historique:
received:
13
07
2023
accepted:
05
02
2024
medline:
29
2
2024
pubmed:
29
2
2024
entrez:
28
2
2024
Statut:
epublish
Résumé
The massive scale-up of long-lasting insecticidal nets (LLIN) has led to a major reduction in malaria burden in many sub-Saharan African (SSA) countries. The World Health Organization (WHO) has recently issued a strong recommendation for the use of chlorfenapyr-pyrethroid LLINs compared to standard pyrethroid-only LLINs in areas of high insecticide resistance intensity. However, there is still a lack of conclusive evidence on the efficacy of piperonyl butoxide-pyrethroid (PBO-py) LLINs, especially in West Africa, where vector composition and resistance mechanisms may be different from vectors in East Africa. This is a three-arm, superiority, triple-blinded, cluster randomised trial, with village as the unit of randomisation. This study conducted in Côte d'Ivoire will evaluate the efficacy on epidemiological and entomological outcomes of (1) the control arm: MAGNet® LN, which contains the pyrethroid, alpha-cypermethrin, (2) VEERALIN® LN, a net combining the synergist PBO and alpha-cypermethrin, and (3) Interceptor® G2 LN, which incorporates chlorfenapyr and alpha-cypermethrin, two adulticides with different mechanisms of action. A total of 33 villages with an average of 200 households per village will be identified, mapped, and randomised in a ratio of 1:1:1. Nets will be distributed at a central point following national guidelines with 1 net for every 2 people. The primary outcome of the trial will be incidence of malaria cases (confirmed by rapid diagnostic test (RDT)) in a cohort of 50 children aged 6 months to 10 years in each cluster, followed for 12 months (active case detection). Secondary outcomes are cross-sectional community prevalence of malaria infection (confirmed by RDT) in the study population at 6 and 12 months post-intervention (50 randomly selected persons per cluster), vector density, entomological inoculation rate (EIR), and phenotypic and genotypic insecticide resistance at baseline and 12 months post-intervention in 3 sentinel villages in each treatment arm. In addition to generating further evidence for next-generation LLINs, this study will also provide the first evidence for pyrethroid-PBO nets in a West African setting. This could further inform WHO recommendations on the pragmatic use of pyrethroid-PBO nets. ClinicalTrials.gov NCT05796193. Registered on April 3, 2023.
Sections du résumé
BACKGROUND
BACKGROUND
The massive scale-up of long-lasting insecticidal nets (LLIN) has led to a major reduction in malaria burden in many sub-Saharan African (SSA) countries. The World Health Organization (WHO) has recently issued a strong recommendation for the use of chlorfenapyr-pyrethroid LLINs compared to standard pyrethroid-only LLINs in areas of high insecticide resistance intensity. However, there is still a lack of conclusive evidence on the efficacy of piperonyl butoxide-pyrethroid (PBO-py) LLINs, especially in West Africa, where vector composition and resistance mechanisms may be different from vectors in East Africa.
METHODS
METHODS
This is a three-arm, superiority, triple-blinded, cluster randomised trial, with village as the unit of randomisation. This study conducted in Côte d'Ivoire will evaluate the efficacy on epidemiological and entomological outcomes of (1) the control arm: MAGNet® LN, which contains the pyrethroid, alpha-cypermethrin, (2) VEERALIN® LN, a net combining the synergist PBO and alpha-cypermethrin, and (3) Interceptor® G2 LN, which incorporates chlorfenapyr and alpha-cypermethrin, two adulticides with different mechanisms of action. A total of 33 villages with an average of 200 households per village will be identified, mapped, and randomised in a ratio of 1:1:1. Nets will be distributed at a central point following national guidelines with 1 net for every 2 people. The primary outcome of the trial will be incidence of malaria cases (confirmed by rapid diagnostic test (RDT)) in a cohort of 50 children aged 6 months to 10 years in each cluster, followed for 12 months (active case detection). Secondary outcomes are cross-sectional community prevalence of malaria infection (confirmed by RDT) in the study population at 6 and 12 months post-intervention (50 randomly selected persons per cluster), vector density, entomological inoculation rate (EIR), and phenotypic and genotypic insecticide resistance at baseline and 12 months post-intervention in 3 sentinel villages in each treatment arm.
DISCUSSION
CONCLUSIONS
In addition to generating further evidence for next-generation LLINs, this study will also provide the first evidence for pyrethroid-PBO nets in a West African setting. This could further inform WHO recommendations on the pragmatic use of pyrethroid-PBO nets.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT05796193. Registered on April 3, 2023.
Identifiants
pubmed: 38419075
doi: 10.1186/s13063-024-07969-2
pii: 10.1186/s13063-024-07969-2
doi:
Banques de données
ClinicalTrials.gov
['NCT05796193']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
151Subventions
Organisme : Global Fund to Fight AIDS, Tuberculosis and Malaria
ID : 2023-000314
Informations de copyright
© 2024. The Author(s).
Références
Fact sheet about malaria. https://www.who.int/news-room/fact-sheets/detail/malaria . Accessed 6 Jun 2023
World Health Organization. (2021). World malaria report 2021. World Health Organization. https://apps.who.int/iris/handle/10665/350147 . License: CC BY-NC-SA 3.0 IGO.
Bhatt S, Weiss DJ, Cameron E, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–11.
doi: 10.1038/nature15535
pubmed: 26375008
pmcid: 4820050
World malaria report 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
WHO-PQ. https://extranet.who.int/pqweb/vector-control-products/prequalified-product-list , 2022.
Protopopoff N, Mosha JF, Lukole E, et al. Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-two factorial design trial. Lancet Lond Engl. 2018;391:1577–88.
doi: 10.1016/S0140-6736(18)30427-6
Staedke SG, Gonahasa S, Dorsey G, et al. Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): a pragmatic, cluster-randomised trial embedded in a national LLIN distribution campaign. Lancet Lond Engl. 2020;395:1292–303.
doi: 10.1016/S0140-6736(20)30214-2
WHO (2017) Conditions for deployment of mosquito nets treated with a pyrethroid and piperonyl butoxide. In: Programme GM, editor. Geneva: World Health Organization.
Gleave K, Lissenden N, Chaplin M, Choi L, Ranson H. Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa. Cochrane Database Syst Rev. 2021;5:CD012776.
pubmed: 34027998
Cisse MBM, Sangare D, Oxborough RM, Dicko A, Dengela D, Sadou A, Mihigo J, George K, Norris L, Fornadel C. A village level cluster-randomized entomological evaluation of combination long-lasting insecticidal nets containing pyrethroid plus PBO synergist in Southern Mali. Malar J. 2017;16:477.
doi: 10.1186/s12936-017-2124-1
pubmed: 29162120
pmcid: 5698970
Oumbouke WA, Rowland M, Koffi AA, Alou LPA, Camara S, N’Guessan R. Evaluation of an alpha-cypermethrin + PBO mixture long-lasting insecticidal net VEERALIN® LN against pyrethroid resistant Anopheles gambiae s.s.: an experimental hut trial in M’bé, central Côte d’Ivoire. Parasit Vectors. 2019;12:544.
doi: 10.1186/s13071-019-3796-x
pubmed: 31730481
pmcid: 6858630
Mosha JF, Kulkarni MA, Lukole E, et al. Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial. The Lancet. 2022;399:1227–41.
doi: 10.1016/S0140-6736(21)02499-5
Accrombessi M, Cook J, Dangbenon E, et al. Efficacy of pyriproxyfen-pyrethroid long-lasting insecticidal nets (LLINs) and chlorfenapyr-pyrethroid LLINs compared with pyrethroid-only LLINs for malaria control in Benin: a cluster-randomised, superiority trial. The Lancet. 2023;401:435–46.
doi: 10.1016/S0140-6736(22)02319-4
WHO publishes recommendations on two new types of insecticide-treated nets. https://www.who.int/news/item/14-03-2023-who-publishes-recommendations-on-two-new-types-of-insecticide-treated-nets . Accessed 12 Jun 2023
Institut National de la Statistique-INS et ICF. Enquête Démographique et de Santé de Côte d’Ivoire, 2021. Rockville, Maryland, USA: INS/Côte d’Ivoire et ICF; 2022.
Glunt KD, Coetzee M, Huijben S, Koffi AA, Lynch PA, N’Guessan R, Oumbouke WA, Sternberg ED, Thomas MB. Empirical and theoretical investigation into the potential impacts of insecticide resistance on the effectiveness of insecticide-treated bed nets. Evol Appl. 2017;11:431–41.
doi: 10.1111/eva.12574
pubmed: 29636797
pmcid: 5891045
Oumbouke WA, Pignatelli P, Barreaux AMG, Tia IZ, Koffi AA, Ahoua Alou LP, Sternberg ED, Thomas MB, Weetman D, N’Guessan R. Fine scale spatial investigation of multiple insecticide resistance and underlying target-site and metabolic mechanisms in Anopheles gambiae in central Côte d’Ivoire. Sci Rep. 2020;10:15066.
doi: 10.1038/s41598-020-71933-8
pubmed: 32934291
pmcid: 7493912
Wolie RZ, Koffi AA, Ayuk-Taylor L, et al. Entomological indicators of malaria transmission prior to a cluster-randomized controlled trial of a ‘lethal house lure’ intervention in central Côte d’Ivoire. Malar J. 2022;21:188.
doi: 10.1186/s12936-022-04196-5
pubmed: 35705981
pmcid: 9202144
Yovogan B, Sovi A, Padonou GG, et al. Pre-intervention characteristics of the mosquito species in Benin in preparation for a randomized controlled trial assessing the efficacy of dual active-ingredient long-lasting insecticidal nets for controlling insecticide-resistant malaria vectors. Plos One. 2021;16:e0251742.
doi: 10.1371/journal.pone.0251742
pubmed: 34014982
pmcid: 8136630
Matowo NS, Martin J, Kulkarni MA, et al. An increasing role of pyrethroid-resistant Anopheles funestus in malaria transmission in the Lake Zone Tanzania. Sci Rep. 2021;11:13457.
doi: 10.1038/s41598-021-92741-8
pubmed: 34188090
pmcid: 8241841
Chan A-W, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
doi: 10.1136/bmj.e7586
pubmed: 23303884
pmcid: 3541470
Rezo-Ivoire .net | le departement de tiebissou. https://rezoivoire.net/ivoire/villes-villages/426/le-departement-de-tiebissou.html . Accessed 6 Jun 2023
Oumbouke WA, Tia IZ, Barreaux AMG, Koffi AA, Sternberg ED, Thomas MB, N’Guessan R. Screening and field performance of powder-formulated insecticides on eave tube inserts against pyrethroid resistant Anopheles gambiae s.l.: an investigation into ‘actives’ prior to a randomized controlled trial in Côte d’Ivoire. Malar J. 2018;17:374.
doi: 10.1186/s12936-018-2517-9
pubmed: 30348154
pmcid: 6196564
The PMI VectorLink Project. The PMI VectorLink Project Annual Report: October 1, 2020–September 30, 2021. Rockville, Maryland: The PMI VectorLink Project, Abt Associates; November 2021.
PNLP:: Documents de référence. https://www.pnlpcotedivoire.org/documents-de-reference/ . Accessed 13 Jun 2023
Technical consultation on determining non-inferiority of vector control products within an established class: report of a virtual meeting, 31 August–2 September 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Mboma ZM, Overgaard HJ, Moore S, Bradley J, Moore J, Massue DJ, Kramer K, Lines J, Lorenz LM. Mosquito net coverage in years between mass distributions: a case study of Tanzania, 2013. Malar J. 2018;17:100.
doi: 10.1186/s12936-018-2247-z
pubmed: 29490649
pmcid: 5831856
Seyoum D, Speybroeck N, Duchateau L, Brandt P, Rosas-Aguirre A. Long-lasting insecticide net ownership, access and use in Southwest Ethiopia: a community-based cross-sectional study. Int J Environ Res Public Health. 2017;14:1312.
doi: 10.3390/ijerph14111312
pubmed: 29077052
pmcid: 5707951
U.S. President’s Malaria Initiative Côte d’Ivoire Malaria Operational Plan FY 2022.
WHO Report of the twentieth WHOPES working group meeting, WHO/HQ, Geneva, 20–24 March 2017.
Mangold KA, Manson RU, Koay ESC, Stephens L, Regner M, Thomson RB, Peterson LR, Kaul KL. Real-time PCR for detection and identification of Plasmodium spp. J Clin Microbiol. 2005;43:2435–40.
doi: 10.1128/JCM.43.5.2435-2440.2005
pubmed: 15872277
pmcid: 1153761
Bass C, Williamson MS, Field LM. Development of a multiplex real-time PCR assay for identification of members of the Anopheles gambiae species complex. Acta Trop. 2008;107:50–3.
doi: 10.1016/j.actatropica.2008.04.009
pubmed: 18490000
WHO. Test procedures for insecticide resistance monitoring in malaria vector mosquitoes. Geneva, Switzerland: World Health Organization; 2016.
Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999;28:319–26.
doi: 10.1093/ije/28.2.319
pubmed: 10342698
Sternberg ED, Cook J, Alou LPA, et al. Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Côte d’Ivoire: a two-arm, cluster-randomised controlled trial. Lancet Lond Engl. 2021;397:805–15.
doi: 10.1016/S0140-6736(21)00250-6
Churcher TS, Lissenden N, Griffin JT, Worrall E, Ranson H. The impact of pyrethroid resistance on the efficacy and effectiveness of bednets for malaria control in Africa. eLife. 2016;5:16090.
doi: 10.7554/eLife.16090
Li G, Taljaard M, Van den Heuvel ER, Levine MA, Cook DJ, Wells GA, Devereaux PJ, Thabane L. An introduction to multiplicity issues in clinical trials: the what, why, when and how. Int J Epidemiol. 2017;46:746–55.
pubmed: 28025257
Proschan MA, Waclawiw MA. Practical guidelines for multiplicity adjustment in clinical trials. Control Clin Trials. 2000;21:527–39.
doi: 10.1016/S0197-2456(00)00106-9
pubmed: 11146147
Mattingly PF. The mosquitoes of Ethiopian Region. London: Sutcliffe; 1971.
Coetzee M. Key to the females of Afrotropical Anopheles mosquitoes (Diptera: Culicidae). Malar J. 2020;19:70.
doi: 10.1186/s12936-020-3144-9
pubmed: 32054502
pmcid: 7020601
Kengne P, Awono-Ambene HP, Antonio-Nkondjio C. Fontenille D (2003) [Development of a PCR (polymerase chain reaction) specific for complex Anopheles nili (Theobald) 1904 species in Cameroon ]. Bull Soc Pathol Exot. 1990;96:165–7.
Rapid high throughput SYBR green assay for identifying the malaria vectors Anopheles arabiensis, Anopheles coluzzii and Anopheles gambiae s.s. Giles | PLOS ONE. https://journals.plos.org/plosone/article?id= https://doi.org/10.1371/journal.pone.0215669 . Accessed 12 Jul 2023
Giraldo-Calderón GI, Emrich SJ, MacCallum RM, et al. VectorBase: an updated bioinformatics resource for invertebrate vectors and other organisms related with human diseases. Nucleic Acids Res. 2015;43:D707-713.
doi: 10.1093/nar/gku1117
pubmed: 25510499
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
doi: 10.1186/s13059-014-0550-8
pubmed: 25516281
pmcid: 4302049
Mavridis K, Wipf N, Medves S, Erquiaga I, Müller P, Vontas J. Rapid multiplex gene expression assays for monitoring metabolic resistance in the major malaria vector Anopheles gambiae. Parasit Vectors. 2019;12:9.
doi: 10.1186/s13071-018-3253-2
pubmed: 30612581
pmcid: 6322220
Lucas ER, Miles A, Harding NJ, Clarkson CS, Lawniczak MKN, Kwiatkowski DP, Weetman D, Donnelly MJ, Anopheles gambiae 1000 Genomes Consortium. Whole-genome sequencing reveals high complexity of copy number variation at insecticide resistance loci in malaria mosquitoes. Genome Res. 2019;29:1250–61.
doi: 10.1101/gr.245795.118
pubmed: 31345938
pmcid: 6673711
Campos M, Phelan J, Spadar A, et al. High-throughput barcoding method for the genetic surveillance of insecticide resistance and species identification in Anopheles gambiae complex malaria vectors. Sci Rep. 2022;12:13893.
doi: 10.1038/s41598-022-17822-8
pubmed: 35974073
pmcid: 9381500
Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf. 1994;10:93–102.
doi: 10.2165/00002018-199410020-00001
pubmed: 8011183
Council for International Organizations of Medical Sciences. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, Switzerland: World Health Organization; 2002.